- Home
- JHI vs BDTX Comparison
JHI vs BDTX Comparison
Compare JHI & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JHI
- BDTX
- Stock Information
- Founded
- JHI 1971
- BDTX 2014
- Country
- JHI United States
- BDTX United States
- Employees
- JHI N/A
- BDTX N/A
- Industry
- JHI Trusts Except Educational Religious and Charitable
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JHI Finance
- BDTX Health Care
- Exchange
- JHI Nasdaq
- BDTX Nasdaq
- Market Cap
- JHI 124.2M
- BDTX 126.2M
- IPO Year
- JHI N/A
- BDTX 2020
- Fundamental
- Price
- JHI $14.13
- BDTX $2.16
- Analyst Decision
- JHI
- BDTX Strong Buy
- Analyst Count
- JHI 0
- BDTX 4
- Target Price
- JHI N/A
- BDTX $15.50
- AVG Volume (30 Days)
- JHI 29.5K
- BDTX 567.4K
- Earning Date
- JHI 01-01-0001
- BDTX 03-11-2025
- Dividend Yield
- JHI 6.80%
- BDTX N/A
- EPS Growth
- JHI N/A
- BDTX N/A
- EPS
- JHI 1.05
- BDTX N/A
- Revenue
- JHI N/A
- BDTX N/A
- Revenue This Year
- JHI N/A
- BDTX N/A
- Revenue Next Year
- JHI N/A
- BDTX N/A
- P/E Ratio
- JHI $12.47
- BDTX N/A
- Revenue Growth
- JHI N/A
- BDTX N/A
- 52 Week Low
- JHI $11.63
- BDTX $1.91
- 52 Week High
- JHI $13.40
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- JHI 53.98
- BDTX 42.32
- Support Level
- JHI $14.15
- BDTX $2.24
- Resistance Level
- JHI $14.24
- BDTX $2.47
- Average True Range (ATR)
- JHI 0.08
- BDTX 0.16
- MACD
- JHI 0.00
- BDTX -0.03
- Stochastic Oscillator
- JHI 54.17
- BDTX 5.69
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.